Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration.

Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K, Chopra R, Faes L, Preston G, Pontikos N, Patel PJ, Tufail A, Lee AY, Balaskas K, Keane PA.

Br J Ophthalmol. 2019 Oct 14. pii: bjophthalmol-2019-314446. doi: 10.1136/bjophthalmol-2019-314446. [Epub ahead of print]

PMID:
31611234
2.

The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes.

Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M, Downey L, Natha S, Chakravarthy U, Bailey C, Khan R, Antcliff R, Armstrong S, Varma A, Kumar V, Tsaloumas M, Mandal K, Bunce C, Tufail A; United Kingdom Age-Related Macular Degeneration Electronic Medical Records Users Group.

Ophthalmology. 2014 Oct;121(10):1966-75. doi: 10.1016/j.ophtha.2014.04.026. Epub 2014 Jun 20.

PMID:
24953791
3.

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.

Parikh R, Avery RL, Saroj N, Thompson D, Freund KB.

JAMA Ophthalmol. 2019 Jul 11. doi: 10.1001/jamaophthalmol.2019.1947. [Epub ahead of print]

PMID:
31294771
4.

Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration.

Stem MS, Moinuddin O, Kline N, Thanos A, Rao P, Williams GA, Hassan TS.

JAMA Ophthalmol. 2018 Jul 1;136(7):820-823. doi: 10.1001/jamaophthalmol.2018.1534.

5.

One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource.

Fasler K, Moraes G, Wagner S, Kortuem KU, Chopra R, Faes L, Preston G, Pontikos N, Fu DJ, Patel P, Tufail A, Lee AY, Balaskas K, Keane PA.

BMJ Open. 2019 Jun 21;9(6):e027441. doi: 10.1136/bmjopen-2018-027441.

6.

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).

Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K.

Ophthalmology. 2016 Jun;123(6):1269-77. doi: 10.1016/j.ophtha.2016.01.033. Epub 2016 Mar 18.

PMID:
26996339
7.

Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.

Gillies MC, Nguyen V, Daien V, Arnold JJ, Morlet N, Barthelmes D.

Ophthalmology. 2016 Dec;123(12):2545-2553. doi: 10.1016/j.ophtha.2016.08.016. Epub 2016 Oct 1. Erratum in: Ophthalmology. 2017 May;124(5):746.

PMID:
27707549
8.

The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity.

Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group.

Ophthalmology. 2014 May;121(5):1092-101. doi: 10.1016/j.ophtha.2013.11.031. Epub 2014 Jan 23.

9.

Aflibercept for neovascular age-related macular degeneration.

Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD.

Cochrane Database Syst Rev. 2016 Feb 8;2:CD011346. doi: 10.1002/14651858.CD011346.pub2. Review.

10.

Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK.

Keenan TD, Kelly SP, Sallam A, Mohamed Q, Tufail A, Johnston RL.

Br J Ophthalmol. 2013 Sep;97(9):1168-72. doi: 10.1136/bjophthalmol-2013-303233. Epub 2013 Jun 28.

PMID:
23813420
11.

Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.

Wolf S, Bandello F, Loewenstein A, Slakter J, Katz T, Sowade O, Korobelnik JF.

Ophthalmologica. 2016;236(2):95-9. doi: 10.1159/000447725. Epub 2016 Jul 23.

12.

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States.

Khanani AM, Skelly A, Bezlyak V, Griner R, Torres LR, Sagkriotis A.

Ophthalmol Retina. 2019 Sep 27. pii: S2468-6530(19)30569-X. doi: 10.1016/j.oret.2019.09.009. [Epub ahead of print]

PMID:
31812631
13.

Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies.

Lanzetta P, Cruess AF, Cohen SY, Slakter JS, Katz T, Sowade O, Zeitz O, Ahlers C, Mitchell P.

Acta Ophthalmol. 2018 Dec;96(8):e911-e918. doi: 10.1111/aos.13751. Epub 2018 Apr 16.

14.

Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.

Mimura K, Matsumoto H, Morimoto M, Akiyama H.

Ophthalmologica. 2018;239(2-3):121-127. doi: 10.1159/000484099. Epub 2017 Nov 23.

PMID:
29169154
15.

Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye.

Bek T, Klug SE.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2061-2068. doi: 10.1007/s00417-018-4100-z. Epub 2018 Aug 10.

PMID:
30097785
16.
17.

UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12.

Lee AY, Lee CS, Butt T, Xing W, Johnston RL, Chakravarthy U, Egan C, Akerele T, McKibbin M, Downey L, Natha S, Bailey C, Khan R, Antcliff R, Varma A, Kumar V, Tsaloumas M, Mandal K, Liew G, Keane PA, Sim D, Bunce C, Tufail A; UK AMD EMR Users Group.

Br J Ophthalmol. 2015 Aug;99(8):1045-50. doi: 10.1136/bjophthalmol-2014-306229. Epub 2015 Feb 13.

18.
19.

Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.

Eleftheriadou M, Vazquez-Alfageme C, Citu CM, Crosby-Nwaobi R, Sivaprasad S, Hykin P, Hamilton RD, Patel PJ.

Am J Ophthalmol. 2017 Feb;174:160-168. doi: 10.1016/j.ajo.2016.09.038. Epub 2016 Oct 14.

PMID:
27746298
20.

Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study.

Bellmann C, Unnebrink K, Rubin GS, Miller D, Holz FG.

Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):968-74. Epub 2003 Sep 6.

PMID:
13680248

Supplemental Content

Support Center